Beeologics to Conduct Clinical Trials
Would you like to be part of a clinical trial for Remebee?  Beeologics is developing a line of projects to improve bee health.  Recently, Beeologics received approval to disseminate Remebee for investigative purposes.  Remebee uses RNAi technology to target Israeli Acute Paralysis Virus, a virus that has been associated with CCD.  Email This e-mail address is being protected from spam bots, you need JavaScript enabled to view it to purchase product for this trial.  The treatment regime begins in December, 2010.
 
< Prev   Next >